Migden, M.; Schmults, C.; Khushalani, N.; Guminski, A. .; Chang, A. L.; Lewis, K. .; Ansstas, G. .; Bowyer, S. .; Hughes, B. .; Schadendorf, D. .; Modi, B. .; Dunn, L. .; Flatz, L. .; Hauschild, A. .; Yoo, S.-Y. .; Booth, J. .; Seebach, F. .; Lowy, I. .; Fury, M. .; Rischin, D. . Phase 2 Study of Cemiplimab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Final Analysis from EMPOWER-CSCC-1 Groups 1, 2, and 3. J of Skin 2023, 7, s176.